HIGHLIGHTS
SUMMARY
The spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reached pandemic proportions as declared by the World Health Organization (WHO) in March 2020, causing the Coronavirus disease 2019 (COVID-19). The heterogeneity of these clinical manifestations is strongly linked to general health conditions, vaccination state, age, and concomitant morbidities (particularly hypertension, obesity, and/or type 2 diabetes) of COVID-19 patients. Visceral Adipose Tissue (VAT) inflammation can be considered a key event that contributes to triggering metabolic dysregulation and amplifying the systemic inflammatory characteristic of COVID-19 patients with metabolic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.